Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Metrics to compare | SBFM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSBFMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.0x | −2.6x | −0.5x | |
PEG Ratio | −0.01 | 0.00 | 0.00 | |
Price/Book | 0.2x | 1.8x | 2.6x | |
Price / LTM Sales | 0.2x | 6.7x | 3.3x | |
Upside (Analyst Target) | - | 85.3% | 44.3% | |
Fair Value Upside | Unlock | 20.7% | 4.9% | Unlock |